Sixth International Conference on Mycetoma

15-17 February 2019
Khartoum, Sudan

The Sixth International Conference on Mycetoma is organized by the Mycetoma Research Centre, University of Khartoum in partnership with the World Health Organisation and the Global Mycetoma Working Group.

DNDi is co-sponsoring the event.

 

Sessions

Mycetoma international collaboration

Date: Saturday, 16 February 2019
Time: 11:00-12:30

Chairs

  • Naeema Al Gasseer, WR-Sudan, Sudan
  • Monique Wasuna, Director DNDi Africa
  • Afia Zafar, Department of Pathology and Laboratory Medicine, The Aga Khan University, Pakistan

Speakers:

  • WHO Representative
  • Global Mycetoma Working Group Representative
  • DNDi Representative
  • CDC Representative
  • Skin NTDs Group Representative
  • Donors Representative
  • International Foundation for Dermatology Chair

 

Mycetoma: The road map

Time: 12:30-14:00

Chairs

  • Marcel Tanner, DNDi Board Treasurer & University of Basel and Federal Institute of Technology, Switzerland
  • El Zein Karrar
  • Daniel Argaw Dagne, Coordinator, Innovative and Intensified Disease Management unit, WHO Department of Control of Neglected Tropical Diseases

Speakers:

  • WHO Representative
  • DNDi Representative
  • CDC Representative
  • Global Mycetoma Working Group Representative
  • Royal Society of Tropical Medicine & Hygiene Representative
  • Skin NTDs Group Representative
  • Patients Representative
  • International Foundation for Dermatology Chair

 

The way forward

Date: Sunday, 17 February 2019
Time: 12:30-14:00

Speakers:

  • Mwele Malecela, Director of the Africa Regional Office, WHO
  • Nathalie Strub-Wourgaft, NTD Director, DNDi, Switzerland
  • Roderick Hay, Consultant Dermatologist, Kings College Hospital, United Kingdom
  • Flavio Queiroz-Telles, Universidade Federal do Paraná, Brazil
  • Ahmed Hassan Fahal, Mycetoma Research Centre, University of Khartoum, Sudan

 

Presentation

Date: Sunday, 17 February 2019
Time: 11:45-12:00

Using the MycetOS approach to pinpoint the chemical properties of the fenarimols needed for in vivo efficacy in Madurella mycetomatis mycetoma
Lim W*, Melse Y, Konings M, Hung Phat Duong, Eadie K, Fahal A, Laleu B, Perry B, Todd M, Ioset JR, van de Sande WWJ

*Presenting author

 

More information: